Chandra Bhagat Pharma Ltd — Board Meeting, 29-05-2025: Board Meeting

Chandra Bhagat Pharma Limited has announced a board meeting approving the financial results for the quarter and half-year ended March 31, 2025, along with the statement of assets and liabilities. The audit report from AY & Company expressed an unmodified opinion, affirming the accuracy of the financial statements and effective internal controls. The company appointed M/s Amit Dharmani & Associates as the Secretarial Auditor for FY 2024-25. Operating cash flows turned negative due to working capital changes, and cash reserves declined significantly year-on-year. Shareholders’ funds rose modestly to ₹29.97 Cr, with long-term borrowings increasing to ₹2.28 Cr.